Evidence Gaps

What do systematic reviews say?

1 questions · 6 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 16.7%Moderate 2 · 33.3%High 3 · 50%

Severe cases of all‐cause diarrhoea · children

Rotarix leads to lower severe cases of all‐cause diarrhoea compared with placebo (high certainty).

6 findings from 1 review

Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.64 [0.52, 0.79]
2 studies · 26479 participants
High
Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.74 [0.5, 1.09]
2 studies · 23317 participants
Low
Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.73 [0.56, 0.95]
2 studies · 5639 participants
High

Show 3 more findings

Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.83 [0.72, 0.96]
1 study · 2764 participants
High
Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.48 [0.37, 0.61]
1 study · 3874 participants
Moderate
Vaccines for preventing rotavirus diarrhoea: vaccines in use 2021 · Cochrane Headline outcomes only
RR 0.49 [0.4, 0.6]
2 studies · 6269 participants
Moderate